Skip to main content
EJNMMI Physics
Download PDF

Using 31P-MRI of hydroxyapatite for bone attenuation correction in PET-MRI: proof of concept in the rodent brain

EJNMMI Physics volume 4, Article number: 16 (2017) Cite this article

Abstract

Background

The correction of γ-photon attenuation in PET-MRI remains a critical issue, especially for bone attenuation. This problem is of great importance for brain studies due to the density of the skull. Current techniques for skull attenuation correction (AC) provide indirect estimates of cortical bone density, leading to inaccurate estimates of brain activity. The purpose of this study was to develop an alternate method for bone attenuation correction based on NMR.

The proposed approach relies on the detection of hydroxyapatite crystals by zero echo time (ZTE) MRI of 31P, providing individual and quantitative assessment of bone density. This work presents a proof of concept of this approach. The first step of the method is a calibration experiment to determine the conversion relationship between the 31P signal and the linear attenuation coefficient μ. Then 31P-ZTE was performed in vivo in rodent to estimate the μ-map of the skull. 18F-FDG PET data were acquired in the same animal and reconstructed with three different AC methods: 31P-based AC, AC neglecting the bone and the gold standard, CT-based AC, used to comparison for the other two methods.

Results

The calibration experiment provided a conversion factor of 31P signal into μ. In vivo 31P-ZTE made it possible to acquire 3D images of the rat skull. Brain PET images showed underestimation of 18F activity in peripheral regions close to the skull when AC neglected the bone (as compared with CT-based AC). The use of 31P-derived μ-map for AC leads to increased peripheral activity, and therefore a global overestimation of brain 18F activity.

Conclusions

In vivo 31P-ZTE MRI of hydroxyapatite provides μ-map of the skull, which can be used for attenuation correction of 18F-FDG PET images. This study is limited by several intrinsic biases associated with the size of the rat brain, which are unlikely to affect human data on a clinical PET-MRI system.

Background

Five years after the introduction of the first whole-body PET/MR systems, attenuation correction of PET images remains challenging. This is particularly true for bone attenuation, due to the inability of 1H-MRI to detect the crystal component of cortical bone. Neglecting bone attenuation leads to significant activity underestimation in bone as well as in neighboring tissues [1, 2], which is of particular concern for the brain given the skull density. Original approaches have been developed to assess skull attenuation by MRI, such as atlas-based, template-based, and segmentation-based methods [3]. However, these approaches provide an indirect assessment of bone density and remain inaccurate in the vicinity of bones [4, 5]. In this context, the ability to measure the density of cortical bone crystal in vivo by MRI would be of great interest. This study presents a new MR-based method for bone attenuation correction, based on 31P-MRI of hydroxyapatite crystals. The method was implemented on preclinical MRI and PET/CT systems in order to provide in vivo proof of concept in rodent. A calibration experiment was first conducted on a bone sample to determine the conversion factor from 31P signal intensity to linear attenuation coefficient μ. Then in vivo MRI and PET/CT were performed on a rat. A μ-map of the skull was calculated from 31P-MRI and used to correct 18F-FDG PET images of the brain for skull attenuation.

Rationale

Bone crystal is made of hydroxyapatite Ca5(PO4)3OH [6], which high density (3.8 kg/L) and high atomic number (Z = 20 for Ca) explain γ-photon attenuation. Hydroxyapatite is hardly detectable by 1H-MRI in vivo. However, each crystal contains three phosphorus atoms that are detectable by 31P-NMR. The NMR spectrum in Fig. 1 displays the total 31P-NMR signal acquired from a rat head in vivo at 11.7 T (Fourier-transformed FID, 15 μs hard pulse for excitation, TR = 15 ms, 66 averages). This spectrum shows that 31P signal is dominated by a broad peak, which can unambiguously be ascribed to solid-state 31P given its short T2 of ~85 μs (FWHM ~18.5 ppm) and long T1 of ~20 s (fitted from spectra acquired for five different TR, data not shown). In contrast, the sharp peaks at −2.5, −5.0, −10.0, and −18.8 ppm belong to the liquid-state phosphorus atoms of PCr and ATP [7]. Integration of the spectrum shows that the liquid signal accounts for 7% of total 31P signal of the head (ratio of ATP + PCr + Pi peak areas divided by the total 31P resonance area). Thus, signal from hydroxyapatite dominates the 31P-NMR signal from the head in vivo. Solid-state 31P MRI techniques, which are appropriate for the detection of nuclei having short T2, have been proposed for MRI of cortical bone [8,9,10,11,12,13,14,15]. Based on these observations, we hypothesized that 31P-ZTE imaging of the head in vivo will provide 3D images of the skull, which can be converted into an attenuation map and used to correct PET data for γ-photon attenuation.

Fig. 1
figure 1

31P-NMR spectrum of a rat head in vivo

Full size image

Methods

Calibration experiment on a cortical bone sample

A U-shape sample was cut out of bovine cortical bone and positioned on top of a saline-filled tube, as shown in Fig. 2a. Saline was necessary for proper NMR shimming and frequency adjustment.

Fig. 2
figure 2

MRI and CT images acquired on the cortical bone sample. 1H anatomical MRI (a), 31P-ZTE MRI (b), fusion (c), and low-resolution CT (d). Note that the rectangular structure in hyposignal located in the center of the inverted U-shape bone in a is a piece of plastic used to position the bone sample on top of the tube

Full size image

MRI data were acquired on a BRUKER BIOSPEC 117/16 USR system. Dedicated radiofrequency (RF) coils were placed on top of the sample (Fig. 2a), made of concentric 1H and 31P surface RF coils used for transmission and reception (15 mm diameter). After RF tuning/matching, shimming, and frequency adjustment, two images of the sample were acquired:

  • 1H anatomical MRI (350 μm isotropic voxel size, proton density weighting) for registration of MRI and CT,

  • 31P-ZTE MRI (1.4 mm isotropic voxel size), using the following parameters: 15 μs 200 W hard pulse for excitation, flip angle close to Ernst angle, 161mT/m readout gradient, 64 points sampled at 250 kHz, FOV = 89.6 mm, TR = 15 ms, 13030 half-projections, 96 averages, 5 h and 13 min acquisition time.

CT data were acquired on a SIEMENS INVEON system:

  • High-resolution CT images of the rat head (103 μm isotropic) for registration of MRI and CT,

  • Low-resolution CT images (860 × 860 × 796 μm) for μ-map generation.

31P-ZTE signal intensity was converted into 31P signal-to-noise ratio (SNR31P) by dividing the 31P signal intensity of each voxel by the standard deviation of the noise measured on a ROI distant from the bone sample. CT images were converted into μ-maps using the established bi-linear relationship between Hounsfield units and μ [16] and then registered to SNR31P images. The conversion factor from SNR31P to μ was obtained by calculating the mean μ/SNR31P ratio. Note that the conversion factor is calculated for a given acquisition time of 31P-ZTE. Its use for 31P data acquired with different acquisition time will require correcting SNR31P for the acquisition time (division by the square root of the acquisition time).

Attenuation correction experiment on rodent head in vivo

A Sprague-Dawley male rat was used for this proof of concept and underwent MRI and PET/CT imaging sessions on the same systems as the bone sample. The PET/CT session was conducted on the rat 5 days after the MRI session. For the two sessions, the rat was positioned in a prone position and anesthetized by inhalation of a ~3% isoflurane/oxygen mixture. During the PET/CT session, the tail vein was catheterized for radiotracer injection. The protocol was approved by the Committee on the Ethics of Animal Experiments of the Commissariat à l’Energie Atomique.

The MRI session was identical to the one performed on the bone sample (acquisition of 1H anatomical MRI and 31P-ZTE MRI with identical parameters, except for 31P-ZTE acquisition which was limited to 16 averages, i.e., 52 min). During the PET/CT session, CT images were acquired with identical parameters as for the bone sample (high resolution for registration, low resolution for attenuation correction) and PET data were acquired in list mode for 60 min following an i.v. bolus of 93 MBq 18F-FDG.

31P-ZTE signal intensity was converted into SNR31P and then into bone μ factor (“μ31P”) using the conversion factor determined on the bone sample (after correcting SNR for the different acquisition time). The PET and CT images were then registered to the μ31P image.

A 1st set of PET images was reconstructed with attenuation correction based on CT generated μ-map (CT-AC PET): PET data were normalized, corrected for scattering, attenuation, arc effects, and physical decay, and reconstructed using a Fourier rebinning algorithm and an iterative OSEM-2D method.

A 2nd set of PET images with attenuation correction neglecting the bone (NoBone-AC PET) was obtained by assuming that the rat head was made of soft tissue and air only. NoBone-AC PET images provide a good approximation of Dixon-based attenuation correction.

A 3rd set of PET images was obtained by adding μ31P to the attenuation map used for the 2nd set of PET images (31 P-AC PET). 31P-AC PET images illustrate the interest of 31P-ZTE over conventional Dixon-based approach.

Results

Figure 2 presents the MRI and CT data acquired on the bone sample, demonstrating excellent co-localization between cortical bone and 31P-ZTE signal, as well as high SNR31P of cortical bone (~30). The conversion factor measured on the sample was μ/SNR31P = 0.0042 ± 0.0004 (cm−1).

The MRI and CT data acquired in vivo are shown in Fig. 3, confirming good co-localization between the skull and 31P-ZTE signal and illustrating the bone specificity of 31P-ZTE MRI (no significant 31P signal from soft tissues). As pointed on Figs. 3c, d, 31P-ZTE seems to “miss” bone spots at the skull base (white arrow). Similarly, “red spots” can be seen outside the skull on Figs. 3b, c. Focal increase in ATP-PCr concentration or soft tissue calcification could theoretically explain these spots. However, the most likely explanation is the contribution of electronic noise, given the low SNR of 31P-ZTE images (~10). A similarity index was calculated between 31P-ZTE and CT skull images, confirming overall good co-localization (0.92 Dice index).

Fig. 3
figure 3

MRI and CT images acquired on the rat head in vivo. 1H anatomical MRI (a), 31P-ZTE MRI (b), fusion (c), and low resolution CT (d). The white arrow points to the skull base where 31P detection sensitivity is impaired

Full size image

Figure 4 displays 18F-FDG PET images of the rat brain reconstructed with the three different attenuation correction methods. In order to illustrate the effect of attenuation correction on brain PET images, 18F activity was measured in a peripheral brain ROI for the three sets of PET images (Fig. 5). As expected for such a small animal, skull attenuation had a limited impact on brain activity. However, Fig. 5 shows that NoBone-AC underestimates 18F activity as compared with CT-AC (p < 0.001, unpaired t test). The use of 31 P-AC significantly increases brain activity as compared with NoBone-AC and overestimates brain activity as compared with CT-AC (p < 0.001).

Fig. 4
figure 4

18F-FDG PET reconstructed using three different attenuation corrections: CT-AC (a), NoBone-AC (b), and 31 P-AC (c)

Full size image
Fig. 5
figure 5

Peripheral brain ROI (a) in which 18F activity was measured for the three different attenuation corrections (b). *p < 0.001

Full size image

Discussion

Specificity of 31P-ZTE for the skull

As shown in Fig. 1, 31P is not only found in mineral hydroxyapatite in vivo but also in liquid-state molecules (mainly PCr and ATP). Moreover, the T1 of PCr or ATP is ~10 times smaller than the T1 of hydroxyapatite [17], such that the short TR used for ZTE is likely to enhance 31P signal of PCr and ATP. This raises the question of possible contamination of the signal of bone voxels by non-apatite molecules on 31P-ZTE images. Both theoretical and experimental data argue against such a contamination. Based on the molar mass of hydroxyapatite (402 g/mol for three phosphorus atoms) and on hydroxyapatite density in bone (3800 g/L), the concentration of 31P atoms in mineral bone can be assessed to ~30 mol/L. This is several orders of magnitude higher than PCr or ATP concentrations in soft tissues (~30 mmol/L for PCr in skeletal muscle [18]). Moreover, cortical bone is mainly made of hydroxyapatite crystals and collagen, with a low cell content [6] so that ATP and PCr concentrations in cortical bone are expected to be much smaller than in soft tissue. Therefore, the contribution of liquid-state molecules to the 31P signal of bone voxels is likely to be negligible as compared to the contribution of hydroxyapatite. This statement is supported by our experimental results: as illustrated by Figs. 3b, c, no significant 31P signal is detected in soft tissues on ZTE images of the rat head. This holds true for skeletal muscle which has the highest PCr and ATP contents among soft tissues [18] and is detected with a higher sensitivity than the skull due to the proximity of the muscle to the surface RF coil. This observation confirms earlier 31P-MRI studies of the wrist bone in vivo [15], showing no detectable signal from skeletal muscle.

Quantitative measurement of bone mineral density

Our data demonstrate the ability to acquire in vivo images of skull hydroxyapatite using 31P-ZTE MRI. They do not demonstrate that 31P signal is quantitatively related to bone density. Such a demonstration would require the use of several bone samples with different densities and comparison with gold standard methods for bone density measurement, which was beyond the scope of this work. However, previous studies on bone samples have demonstrated that solid-state 31P-MRI is as good as or better than dual-energy X-ray absorptiometry in measuring bone mineral density by validation against chemical analysis [14]. Our approach relying on 31P-ZTE, it can therefore be considered to be quantitative for skull attenuation correction, as opposed to the currently available methods such as atlas-based, template-based, or segmentation-based methods [3].

Homogeneity of MRI transmit and receive profiles

One limitation of our study is the use of surface coils for MRI acquisitions, resulting in a decreasing sensitivity from the cranial vertex to the skull base. This detection bias can be observed by comparing 31P-ZTE (Fig. 3c) and CT (Fig. 3d): part of the skull base seen on CT is missing on 31P-ZTE (white arrow). This bias is even more pronounced for the rat jaw which is not detected. However, the 31P coil is optimized for brain detection so that cortical bone is properly taken into account when located in close contact to the brain. It must be noted that the excitation profile may also vary with the flip angle. However, the transmission power was calibrated in order to maximize the broad peak of the 31P spectrum so that the effective flip angle was close to the Ernst angle of the bone, i.e., ~2°. At a low angle such as this one, the excitation profile is rather insensitive to the flip angle.

Another source of inhomogeneity of 31P signal is the frequency profile of the hard pulse used for excitation. A 15 μs hard pulse has a sinc-shape excitation profile for which the central lobe is ~130 kHz. Excitation can be considered to be reasonably homogeneous if all signals are located within the middle 35% of the profile (~45 kHz) where their intensity variation will be less than 5% of the maximum intensity. In practice, it means that 45/250 of the readout FOV will be properly excited, i.e., 16 mm. This value was adapted to our sample experiment (~8 mm largest dimension for the bone sample). For the in vivo experiment, the largest dimension of the skull is ~25 mm, for which the excitation profile cannot be considered to be homogeneous, leading to a signal decrease of 10–15% even when the skull is properly centered in the gradient coil.

Attenuation correction of 18F-FDG PET images of the brain

Measurement of the 18F activity on reconstructed PET images shows an underestimation of brain activity when bone is neglected in the attenuation correction (Fig. 5). This observation is consistent with human studies reporting decreased cortical activity when the skull is assimilated with the soft tissue [4]. The use of 31P-ZTE for skull attenuation increases 18F activity as compared to the activity when NoBone-AC is used but also as compared to the activity when CT-AC is used. This reveals an overestimation of 18F activity by the 31P-based approach, corresponding to an overestimation of skull density. Besides measurement noise, a possible explanation for this overestimation is the inaccuracy of the conversion factor used to derive μ31P from 31P-ZTE MRI: this factor was determined during a separate experiment performed on a bone sample imaged using the same MRI and CT systems. Different coil loading by the bone sample and the rat head might explain 31P sensitivity differences between the two experiments. Another explanation for inaccurate conversion factor could be chemical differences between the bovine sample and the rat skull. The attenuation of γ-photons by the bone is mostly due to calcium (atomic number Z = 20 versus Z = 15 for phosphorus): indeed interactions between photons and mineral bone are dominated by photoelectric effect for which μ∝Z 4 [19] so that attenuation by one Ca atom is ~3 times as high as attenuation by one P atom. Since 31P-ZTE detects phosphorus atoms, the conversion factor determined on our bovine sample would not apply to the rat skull if the Ca/P ratio were significantly different between species or bones. A literature review on the chemical properties of mineral bone reveals that hydroxyapatite Ca5(PO4)3OH is partly affected by lattice substitution, i.e., substitution of Ca2+ or PO4 3− by carbonate (CO3 2−) or hydrogen phosphate (HPO4 2−) [20]. However, lattice substitution affects only 5–10% of bone apatite [21]. In addition, a large majority of lattice substitution corresponds to carbonate located in PO4 3− sites [22, 23], with negligible impact on photon attenuation. Finally, the fraction of PO4 3− substitution by carbonate appears remarkably constant among vertebrate species [23]. Altogether, these observations argue in favor of a constant Ca/P ratio in cortical bone, close to the 5/3 stoechiometric ratio of hydroxyapatite.

Limitations in rodent

This work has several technical limitations mostly due to the small size of the rat brain (~25 mm) in which MRI and PET detection sensitivities are significantly lower than in humans and attenuation of γ-photons is also much smaller than in humans. Moreover, the use of surface RF coils leads to significant bias in 31P sensitivity throughout the skull. Given these limitations, this work cannot claim to quantify the performance of 31P-based attenuation correction. In particular, difference maps or correlation scores—which are standard tools to compare attenuation corrections in humans [3, 24]—are dominated by biases and measurement noise. Indeed, none of the currently available methods for skull AC have been quantitatively assessed in small animals. This study presents an original approach, demonstrating the ability to obtain 3D images of the skull using 31P-ZTE MRI in vivo and presents an implementation for attenuation correction of brain 18F-FDG PET.

Conclusions

This work brings theoretical and experimental arguments justifying the implementation and assessment of 31P-ZTE-based attenuation correction on human PET-MRI systems. The 31P approach should prove more straightforward and robust on a clinical imaging system. The first advantage of a human system will be the suppression of 31P-ZTE sensitivity in homogeneities. MRI of the human brain is performed with homogeneous volume RF coils, which are rarely used in rodent for geometrical reasons. Another advantage will be the suppression of the separate calibration experiment on bone sample, which is a major source of inaccuracy. The geometry of human RF coils will make it possible to insert a bone sample of known μ inside the 31P coil so that 31P signal can be directly converted into μ31P by comparing the signal of the skull with the signal of the sample in the same image. Finally, implementation on a hybrid PET-MRI system will improve the correction accuracy over our experimental setup by suppressing bias associated with registration errors. Implementation on a human hybrid PET-MRI system will make it possible to carefully compare the 31P-based method with currently available methods.

Abbreviations

CT:

Computed tomography

FDG:

Fluorodeoxyglucose

MRI:

Magnetic resonance imaging

NMR:

Nuclear magnetic resonance

PET:

Positron emission tomography

RF:

Radiofrequency

ZTE:

Zero echo time

References

  1. Samarin A, Burger C, Wollenweber SD, Crook DW, Burger IA, Schmid DT, et al. PET/MR imaging of bone lesions—implications for PET quantification from imperfect attenuation correction. Eur J Nucl Med Mol Imaging. 2012;39:1154–60.

    Article  PubMed  Google Scholar 

  2. Wagenknecht G, Kaiser H-J, Mottaghy FM, Herzog H. MRI for attenuation correction in PET: methods and challenges. Magn Reson Mater Phys Biol Med. 2013;26:99–113.

    Article  Google Scholar 

  3. Cabello J, Lukas M, Rota Kops E, Ribeiro A, Shah NJ, Yakushev I, et al. Comparison between MRI-based attenuation correction methods for brain PET in dementia patients. Eur J Nucl Med Mol Imaging. 2016;43:2190–200.

    Article  CAS  PubMed  Google Scholar 

  4. Dickson JC, O’Meara C, Barnes A. A comparison of CT- and MR-based attenuation correction in neurological PET. Eur J Nucl Med Mol Imaging. 2014;41:1176–89.

    Article  PubMed  Google Scholar 

  5. Sekine T, ter Voert EEGW, Warnock G, Buck A, Huellner M, Veit-Haibach P, et al. Clinical evaluation of zero-echo-time attenuation correction for brain 18 F-FDG PET/MRI: comparison with atlas attenuation correction. J Nucl Med. 2016;57:1927–32.

    Article  PubMed  Google Scholar 

  6. Bourne GH, editor. Biochemistry and physiology of bone. 2nd ed. New York: Acad. Press; 1972.

    Google Scholar 

  7. Buchli R, Martin E, Boesiger P. Comparison of calibration strategies for the in vivo determination of absolute metabolite concentrations in the human brain by 31P MRS. NMR Biomed. 1994;7:225–30.

    Article  CAS  PubMed  Google Scholar 

  8. Anumula S, Magland J, Wehrli SL, Zhang H, Ong H, Song HK, et al. Measurement of phosphorus content in normal and osteomalacic rabbit bone by solid-state 3D radial imaging. Magn Reson Med. 2006;56:946–52.

    Article  CAS  PubMed  Google Scholar 

  9. Anumula S, Magland J, Wehrli SL, Ong H, Song HK, Wehrli FW. Multi-modality study of the compositional and mechanical implications of hypomineralization in a rabbit model of osteomalacia. Bone. 2008;42:405–13.

    Article  CAS  PubMed  Google Scholar 

  10. Cao H, Nazarian A, Ackerman JL, Snyder BD, Rosenberg AE, Nazarian RM, et al. Quantitative 31P NMR spectroscopy and 1H MRI measurements of bone mineral and matrix density differentiate metabolic bone diseases in rat models. Bone. 2010;46:1582–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Anumula S, Wehrli SL, Magland J, Wright AC, Wehrli FW. Ultra-short echo-time MRI detects changes in bone mineralization and water content in OVX rat bone in response to alendronate treatment. Bone. 2010;46:1391–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Seifert AC, Li C, Rajapakse CS, Bashoor-Zadeh M, Bhagat YA, Wright AC, et al. Bone mineral 31P and matrix-bound water densities measured by solid-state 31P and 1H MRI. NMR Biomed. 2014;27:739–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Seifert AC, Wehrli FW. Solid-state quantitative 1H and 31P MRI of cortical bone in humans. Curr Osteoporos Rep. 2016;14:77–86.

    Article  PubMed  Google Scholar 

  14. Wu Y, Ackerman JL, Chesler DA, Li J, Neer RM, Wang J, et al. Evaluation of bone mineral density using three-dimensional solid state phosphorus-31 NMR projection imaging. Calcif Tissue Int. 1998;62:512–8.

    Article  CAS  PubMed  Google Scholar 

  15. Wu Y, Reese TG, Cao H, Hrovat MI, Toddes SP, Lemdiasov RA, et al. Bone mineral imaged in vivo by 31P solid state MRI of human wrists. J Magn Reson Imaging. 2011;34:623–33.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Burger C, Goerres G, Schoenes S, Buck A, Lonn A, von Schulthess G. PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients. Eur J Nucl Med Mol Imaging. 2002;29:922–7.

    Article  CAS  PubMed  Google Scholar 

  17. Bogner W, Chmelik M, Schmid AI, Moser E, Trattnig S, Gruber S. Assessment of 31 P relaxation times in the human calf muscle: A comparison between 3 T and 7 T in vivo. Magn Reson Med. 2009;62:574–82.

    Article  CAS  PubMed  Google Scholar 

  18. Kemp GJ, Meyerspeer M, Moser E. Absolute quantification of phosphorus metabolite concentrations in human musclein vivo by 31P MRS: a quantitative review. NMR Biomed. 2007;20:555–65.

    Article  CAS  PubMed  Google Scholar 

  19. Alvarez RE, Macovski A. Energy-selective reconstructions in X-ray computerized tomography. Phys Med Biol. 1976;21:733–44.

    Article  CAS  PubMed  Google Scholar 

  20. Rey C, Combes C, Drouet C, Glimcher MJ. Bone mineral: update on chemical composition and structure. Osteoporos Int. 2009;20:1013–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Roufosse AH, Aue WP, Roberts JE, Glimcher MJ, Griffin RG. Investigation of the mineral phases of bone by solid-state phosphorus-31 magic angle sample spinning nuclear magnetic resonance. Biochemistry (Mosc). 1984;23:6115–20.

    Article  CAS  Google Scholar 

  22. Biltz RM, Pellegrino ED. The nature of bone carbonate. Clin Orthop. 1977;129:279–92.

  23. Rey C, Collins B, Goehl T, Dickson IR, Glimcher MJ. The carbonate environment in bone mineral: a resolution-enhanced Fourier transform infrared spectroscopy study. Calcif Tissue Int. 1989;45:157–64.

    Article  CAS  PubMed  Google Scholar 

  24. Delso G, Wiesinger F, Sacolick LI, Kaushik SS, Shanbhag DD, Hullner M, et al. Clinical evaluation of zero-echo-time MR Imaging for the segmentation of the skull. J Nucl Med. 2015;56:417–22.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Boucherie Chaussepied et l'Avallonnaise (Paris, France) for providing the bovine cortical bone used in this study, Dr. Catriona Wimberley for careful reading of the manuscript, and Dr. Frédérique Frouin for Dice index calculation.

Author’s contributions

VL contributed to the study design, MRI acquisitions (bone sample), and manuscript writing. SJ contributed to the PET/CT acquisitions, PET/CT reconstruction, image registration and quantification, and manuscript correction. YF contributed to the PET/CT acquisitions, PET/CT reconstruction, and image registration and quantification. BT contributed to the animal handling and MRI acquisitions (rodent). GP contributed to the animal handling. EJ contributed to the animal handling and PET/CT acquisitions. JV contributed to the MRI sequence development, MRI acquisitions, and manuscript correction. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Ethics approval

The protocol was approved by the Committee on the Ethics of Animal Experiments of the Commissariat à l’Energie Atomique.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author information

Authors and Affiliations

  1. Commissariat à l’Energie Atomique et aux Energies Alternatives (CEA), Direction de la Recherche Fondamentale (DRF), Institut d’Imagerie Biomedicale (I2BM), MIRCen, Fontenay-aux-Roses, France

    Vincent Lebon, Brice Tiret & Julien Valette

  2. Centre National de la Recherche Scientifique (CNRS), Neurodegenerative Diseases Laboratory, Université Paris-Sud, Université Paris-Saclay, UMR 9199, Fontenay-aux-Roses, France

    Vincent Lebon, Brice Tiret & Julien Valette

  3. Commissariat à l’Energie Atomique et aux Energies Alternatives (CEA), Direction de la Recherche Fondamentale (DRF), Institut d’Imagerie Biomedicale (I2BM), SHFJ, Orsay, France

    Sébastien Jan, Yoann Fontyn, Géraldine Pottier & Emilie Jaumain

  4. Inserm/CEA/Université Paris Sud, Université Paris-Saclay, UMR 1023—CNRS ERL 9218, IMIV, Orsay, France

    Sébastien Jan, Yoann Fontyn, Géraldine Pottier & Emilie Jaumain

Authors
  1. Vincent Lebon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sébastien Jan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoann Fontyn
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Brice Tiret
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Géraldine Pottier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Emilie Jaumain
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Julien Valette
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vincent Lebon.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lebon, V., Jan, S., Fontyn, Y. et al. Using 31P-MRI of hydroxyapatite for bone attenuation correction in PET-MRI: proof of concept in the rodent brain. EJNMMI Phys 4, 16 (2017). https://doi.org/10.1186/s40658-017-0183-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40658-017-0183-6

Keywords